Encouragingly, HE improved the central cholinergic system function of AD mice, as demonstrated by its dose-dependent enhancement of Ach and ChAT concentrations in both serum and the hypothalamus (p < 0.05; Figure 5). This evidence concerns the gene FGFR3 and Alzheimer disease.